_id
6915f023bc934aba376b1fb1
Ticker
RNAZ
Name
Transcode Therapeutics Inc
Exchange
NASDAQ
Address
6 Liberty Square, Boston, MA, United States, 02109
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.transcodetherapeutics.com
Description
TransCode Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer. The company's lead therapeutic candidate comprises TTX-MC138 that targets microRNA-10b, a master regulator of metastatic cell viability in various cancers comprising breast, pancreatic, ovarian, colon cancer, glioblastomas, and others. Its preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1 and two indication agnostic programs; TTX-RIGA, an RNA- based agonist of the retinoic acid-inducible gene I targeting activation of innate immunity in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9-based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines that activate cytotoxic immune responses against tumor cells. TransCode Therapeutics, Inc. has strategic collaboration agreement with The University of Texas M. D. Anderson Cancer Center. The company was incorporated in 2016 and is based in Boston, Massachusetts.
Last Close
10.42
Volume
6383
Current Price
9.51
Change
-8.733205374280232
Last Updated
2025-12-03T13:02:36.571Z
Image
-
Ipo Date
2021-07-08T00:00:00.000Z
Market Cap
8206863
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
10
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
4781
Gross Profit
-4781
Operating Expenses
4556419
Operating Income
-4561200
Interest Expense
5960
Pretax Income
-4856051
Net Income
-4856051
Eps
-5.824817106742011
Dividends Per Share
-
Shares Outstanding
916968
Income Tax Expense
-
EBITDA
-4845310
Operating Margin
-
Total Other Income Expense Net
-294851
Cash
2835916000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
4751048000
Property Plant Equipment
19908000
Total Assets
5226682000
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
3800703000
Equity
1425979000
Depreciation
4781
Change In Working Capital
354612
Cash From Operations
-4083173
Capital Expenditures
3
Cash From Investing
-
Cash From Financing
-455726
Net Change In Cash
-4538899
PE
-
PB
0.006091938843419153
ROE
-0.3405415507521499
ROA
-0.09290886646633563
FCF
-4083176
Fcf Percent
-
Piotroski FScore
1
Health Score
28
Deep Value Investing Score
5
Defensive Investing Score
3.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
8
Quality Investing Score
1
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
4781
Quarters > 0 > income Statement > gross Profit
-4781
Quarters > 0 > income Statement > operating Expenses
4556419
Quarters > 0 > income Statement > operating Income
-4561200
Quarters > 0 > income Statement > interest Expense
5960
Quarters > 0 > income Statement > pretax Income
-4856051
Quarters > 0 > income Statement > net Income
-4856051
Quarters > 0 > income Statement > eps
-5.824817106742011
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
833683
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-4845310
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-294851
Quarters > 0 > balance Sheet > cash
2835916000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
4751048000
Quarters > 0 > balance Sheet > property Plant Equipment
19908000
Quarters > 0 > balance Sheet > total Assets
5226682000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3800703000
Quarters > 0 > balance Sheet > equity
1425979000
Quarters > 0 > cash Flow > net Income
-4856051
Quarters > 0 > cash Flow > depreciation
4781
Quarters > 0 > cash Flow > change In Working Capital
354612
Quarters > 0 > cash Flow > cash From Operations
-4083173
Quarters > 0 > cash Flow > capital Expenditures
3
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-455726
Quarters > 0 > cash Flow > net Change In Cash
-4538899
Quarters > 0 > ratios > PE
-5.824817106742011
Quarters > 0 > ratios > PB
0.006091938843419153
Quarters > 0 > ratios > ROE
-0.3405415507521499
Quarters > 0 > ratios > ROA
-0.09290886646633563
Quarters > 0 > ratios > FCF
-4083176
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
28
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
13443
Quarters > 1 > income Statement > gross Profit
-13443
Quarters > 1 > income Statement > operating Expenses
4221134
Quarters > 1 > income Statement > operating Income
-4221134
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-4276502
Quarters > 1 > income Statement > net Income
-4276502
Quarters > 1 > income Statement > eps
-5.129828442015512
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
833654
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4263060
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-55368
Quarters > 1 > balance Sheet > cash
7374815
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
176122
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
8241721
Quarters > 1 > balance Sheet > property Plant Equipment
24689
Quarters > 1 > balance Sheet > total Assets
8266410
Quarters > 1 > balance Sheet > payables
1362800
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2118704
Quarters > 1 > balance Sheet > equity
6147706
Quarters > 1 > cash Flow > net Income
-4276502
Quarters > 1 > cash Flow > depreciation
13443
Quarters > 1 > cash Flow > change In Working Capital
-224503
Quarters > 1 > cash Flow > cash From Operations
-4194339
Quarters > 1 > cash Flow > capital Expenditures
1
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
8845942000
Quarters > 1 > cash Flow > net Change In Cash
-4194339
Quarters > 1 > ratios > PE
-5.129828442015512
Quarters > 1 > ratios > PB
1.4129944860733417
Quarters > 1 > ratios > ROE
-69.56256528858081
Quarters > 1 > ratios > ROA
-51.733485273534704
Quarters > 1 > ratios > FCF
-4194340
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
51174
Quarters > 2 > income Statement > gross Profit
-51174
Quarters > 2 > income Statement > operating Expenses
3120005
Quarters > 2 > income Statement > operating Income
-3171179
Quarters > 2 > income Statement > interest Expense
114
Quarters > 2 > income Statement > pretax Income
-12085413
Quarters > 2 > income Statement > net Income
-12085413
Quarters > 2 > income Statement > eps
-70.1575690376812
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
172261
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-12034126
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-8914234
Quarters > 2 > balance Sheet > cash
11569000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
322436
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
13044000
Quarters > 2 > balance Sheet > property Plant Equipment
38131
Quarters > 2 > balance Sheet > total Assets
13194000
Quarters > 2 > balance Sheet > payables
2427963
Quarters > 2 > balance Sheet > short Term Debt
38291
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2902000
Quarters > 2 > balance Sheet > equity
10293000
Quarters > 2 > cash Flow > net Income
-12085000
Quarters > 2 > cash Flow > depreciation
51174
Quarters > 2 > cash Flow > change In Working Capital
-455000
Quarters > 2 > cash Flow > cash From Operations
-3097000
Quarters > 2 > cash Flow > capital Expenditures
500
Quarters > 2 > cash Flow > cash From Investing
-500
Quarters > 2 > cash Flow > cash From Financing
8855000
Quarters > 2 > cash Flow > net Change In Cash
5758000
Quarters > 2 > ratios > PE
-70.1575690376812
Quarters > 2 > ratios > PB
0.17438643932769843
Quarters > 2 > ratios > ROE
-117.41390265228797
Quarters > 2 > ratios > ROA
-91.59779445202365
Quarters > 2 > ratios > FCF
-3097500
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-284482
Quarters > 3 > income Statement > gross Profit
284482
Quarters > 3 > income Statement > operating Expenses
2165411
Quarters > 3 > income Statement > operating Income
-2127581
Quarters > 3 > income Statement > interest Expense
10793
Quarters > 3 > income Statement > pretax Income
-2351988
Quarters > 3 > income Statement > net Income
-2351988
Quarters > 3 > income Statement > eps
-6.604574365022535
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
356115
Quarters > 3 > income Statement > income Tax Expense
179479
Quarters > 3 > income Statement > EBITDA
-21342
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-186577
Quarters > 3 > balance Sheet > cash
5811064
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
7093338
Quarters > 3 > balance Sheet > property Plant Equipment
89305
Quarters > 3 > balance Sheet > total Assets
7294499
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
9313233
Quarters > 3 > balance Sheet > equity
-2018734
Quarters > 3 > cash Flow > net Income
-5915958
Quarters > 3 > cash Flow > depreciation
122855
Quarters > 3 > cash Flow > change In Working Capital
942349
Quarters > 3 > cash Flow > cash From Operations
-3146337
Quarters > 3 > cash Flow > capital Expenditures
500
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
7082039
Quarters > 3 > cash Flow > net Change In Cash
3935202
Quarters > 3 > ratios > PE
-6.604574365022535
Quarters > 3 > ratios > PB
-1.8381412806243913
Quarters > 3 > ratios > ROE
116.50806891844097
Quarters > 3 > ratios > ROA
-32.243311021085894
Quarters > 3 > ratios > FCF
-3146837
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
534857
Annuals > 0 > income Statement > gross Profit
-534857
Annuals > 0 > income Statement > operating Expenses
15125840
Annuals > 0 > income Statement > operating Income
-15660697
Annuals > 0 > income Statement > interest Expense
26813
Annuals > 0 > income Statement > pretax Income
-16754971
Annuals > 0 > income Statement > net Income
-16754971
Annuals > 0 > income Statement > eps
-47.049326762422254
Annuals > 0 > income Statement > dividends Per Share
30601000
Annuals > 0 > income Statement > shares Outstanding
356115
Annuals > 0 > income Statement > income Tax Expense
-16785572000
Annuals > 0 > income Statement > EBITDA
-16193302
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-1094274
Annuals > 0 > balance Sheet > cash
5811064
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
7093338
Annuals > 0 > balance Sheet > property Plant Equipment
89305
Annuals > 0 > balance Sheet > total Assets
7294499
Annuals > 0 > balance Sheet > payables
2576098
Annuals > 0 > balance Sheet > short Term Debt
38291
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
9313233
Annuals > 0 > balance Sheet > equity
-2018733
Annuals > 0 > cash Flow > net Income
-16754971
Annuals > 0 > cash Flow > depreciation
534857
Annuals > 0 > cash Flow > change In Working Capital
-351479
Annuals > 0 > cash Flow > cash From Operations
-13335947
Annuals > 0 > cash Flow > capital Expenditures
21761
Annuals > 0 > cash Flow > cash From Investing
-21761
Annuals > 0 > cash Flow > cash From Financing
16401174
Annuals > 0 > cash Flow > net Change In Cash
3043466
Annuals > 0 > ratios > PE
-47.049326762422254
Annuals > 0 > ratios > PB
-1.5788265461554352
Annuals > 0 > ratios > ROE
829.9745929749006
Annuals > 0 > ratios > ROA
-229.69323869946382
Annuals > 0 > ratios > FCF
-13357708
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
516746
Annuals > 1 > income Statement > gross Profit
-516746
Annuals > 1 > income Statement > operating Expenses
18901770
Annuals > 1 > income Statement > operating Income
-19418516
Annuals > 1 > income Statement > interest Expense
55899
Annuals > 1 > income Statement > pretax Income
-18546095
Annuals > 1 > income Statement > net Income
-18546095
Annuals > 1 > income Statement > eps
-3419.00055674155
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
5424.42
Annuals > 1 > income Statement > income Tax Expense
4
Annuals > 1 > income Statement > EBITDA
-17973450
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
872421
Annuals > 1 > balance Sheet > cash
2767598
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
4455444
Annuals > 1 > balance Sheet > property Plant Equipment
602401
Annuals > 1 > balance Sheet > total Assets
5169701
Annuals > 1 > balance Sheet > payables
2331872
Annuals > 1 > balance Sheet > short Term Debt
412280
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3528887
Annuals > 1 > balance Sheet > equity
1640814
Annuals > 1 > cash Flow > net Income
-18546095
Annuals > 1 > cash Flow > depreciation
516746
Annuals > 1 > cash Flow > change In Working Capital
-1082075
Annuals > 1 > cash Flow > cash From Operations
-18074535
Annuals > 1 > cash Flow > capital Expenditures
35609
Annuals > 1 > cash Flow > cash From Investing
-35609
Annuals > 1 > cash Flow > cash From Financing
15909324
Annuals > 1 > cash Flow > net Change In Cash
-2200820
Annuals > 1 > ratios > PE
-3419.00055674155
Annuals > 1 > ratios > PB
0.029588094080133395
Annuals > 1 > ratios > ROE
-1130.2984372390777
Annuals > 1 > ratios > ROA
-358.7459893715323
Annuals > 1 > ratios > FCF
-18110144
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
19
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
98606
Annuals > 2 > income Statement > gross Profit
-98606
Annuals > 2 > income Statement > operating Expenses
18567208
Annuals > 2 > income Statement > operating Income
-18665814
Annuals > 2 > income Statement > interest Expense
17564968
Annuals > 2 > income Statement > pretax Income
-17564968
Annuals > 2 > income Statement > net Income
-17564968
Annuals > 2 > income Statement > eps
-1082.8535848591332
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
16221
Annuals > 2 > income Statement > income Tax Expense
17564968
Annuals > 2 > income Statement > EBITDA
-17466362
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1100846
Annuals > 2 > balance Sheet > cash
4968418
Annuals > 2 > balance Sheet > short Term Investments
9410
Annuals > 2 > balance Sheet > receivables
360229
Annuals > 2 > balance Sheet > inventories
554330
Annuals > 2 > balance Sheet > total Current Assets
7379405
Annuals > 2 > balance Sheet > property Plant Equipment
208581
Annuals > 2 > balance Sheet > total Assets
7587986
Annuals > 2 > balance Sheet > payables
4124812
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
4347290
Annuals > 2 > balance Sheet > equity
3240696
Annuals > 2 > cash Flow > net Income
-17564968
Annuals > 2 > cash Flow > depreciation
98606
Annuals > 2 > cash Flow > change In Working Capital
1308521
Annuals > 2 > cash Flow > cash From Operations
-15762512
Annuals > 2 > cash Flow > capital Expenditures
100918
Annuals > 2 > cash Flow > cash From Investing
-100919
Annuals > 2 > cash Flow > cash From Financing
5989
Annuals > 2 > cash Flow > net Change In Cash
-15857442
Annuals > 2 > ratios > PE
-1082.8535848591332
Annuals > 2 > ratios > PB
0.04479838590228766
Annuals > 2 > ratios > ROE
-542.0122097228497
Annuals > 2 > ratios > ROA
-231.48392735569098
Annuals > 2 > ratios > FCF
-15863430
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
42470
Annuals > 3 > income Statement > gross Profit
-42470
Annuals > 3 > income Statement > operating Expenses
6108665
Annuals > 3 > income Statement > operating Income
-6151135
Annuals > 3 > income Statement > interest Expense
95070
Annuals > 3 > income Statement > pretax Income
-6843399
Annuals > 3 > income Statement > net Income
-6843399
Annuals > 3 > income Statement > eps
-424.265282083075
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
16130
Annuals > 3 > income Statement > income Tax Expense
95070
Annuals > 3 > income Statement > EBITDA
-6705857
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-692264
Annuals > 3 > balance Sheet > cash
20825860
Annuals > 3 > balance Sheet > short Term Investments
9.41
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
22732175
Annuals > 3 > balance Sheet > property Plant Equipment
206268
Annuals > 3 > balance Sheet > total Assets
22938443
Annuals > 3 > balance Sheet > payables
2016331
Annuals > 3 > balance Sheet > short Term Debt
2016331
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2534097
Annuals > 3 > balance Sheet > equity
20404346
Annuals > 3 > cash Flow > net Income
-6843399
Annuals > 3 > cash Flow > depreciation
42470
Annuals > 3 > cash Flow > change In Working Capital
432386
Annuals > 3 > cash Flow > cash From Operations
-5266885
Annuals > 3 > cash Flow > capital Expenditures
254820
Annuals > 3 > cash Flow > cash From Investing
-251820
Annuals > 3 > cash Flow > cash From Financing
25516549
Annuals > 3 > cash Flow > net Change In Cash
19997844
Annuals > 3 > ratios > PE
-424.265282083075
Annuals > 3 > ratios > PB
0.007075134875677955
Annuals > 3 > ratios > ROE
-33.5389284224057
Annuals > 3 > ratios > ROA
-29.833755499446934
Annuals > 3 > ratios > FCF
-5521705
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-5.824817106742011
Valuation > metrics > PB
0.006091938843419153
Valuation > final Score
70
Valuation > verdict
99.4% Undervalued
Profitability > metrics > ROE
-0.3405415507521499
Profitability > metrics > ROA
-0.1022101018554222
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.665328872304571
Risk > metrics > Interest Coverage
-765.3020134228188
Risk > final Score
-3043
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
50
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
55
Prev Risks > 0
-1196
Prev Risks > 1
-111209
Prev Risks > 2
-759
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
50
Updated At
2025-12-12T21:42:12.279Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-17
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-5.8248
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-5.13
Earnings History > 1 > eps Estimate
-1.64
Earnings History > 1 > eps Difference
-3.49
Earnings History > 1 > surprise Percent
-212.8049
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-15
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1286.15
Earnings History > 2 > eps Estimate
-89.88
Earnings History > 2 > eps Difference
-1196.27
Earnings History > 2 > surprise Percent
-1330.9635
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-28
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1286.1487
Earnings History > 3 > eps Estimate
-89.88
Earnings History > 3 > eps Difference
-1196.2687
Earnings History > 3 > surprise Percent
-1330.9621
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-147.84
Earnings History > 4 > eps Estimate
-452.76
Earnings History > 4 > eps Difference
304.92
Earnings History > 4 > surprise Percent
67.3469
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-16
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-27350.416
Earnings History > 5 > eps Estimate
-21436.812
Earnings History > 5 > eps Difference
-5913.604
Earnings History > 5 > surprise Percent
-27.5862
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-04-01
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-22.84
Earnings History > 6 > eps Estimate
-10.8
Earnings History > 6 > eps Difference
-12.04
Earnings History > 6 > surprise Percent
-111.4815
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-29
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-627.3306
Earnings History > 7 > eps Estimate
-356.4004
Earnings History > 7 > eps Difference
-270.9302
Earnings History > 7 > surprise Percent
-76.0185
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.68
Earnings History > 8 > eps Estimate
-1.5
Earnings History > 8 > eps Difference
-0.18
Earnings History > 8 > surprise Percent
-12
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-3.29
Earnings History > 9 > eps Estimate
-3.39
Earnings History > 9 > eps Difference
0.1
Earnings History > 9 > surprise Percent
2.9499
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.38
Earnings History > 10 > eps Estimate
-0.38
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.4
Earnings History > 11 > eps Estimate
-0.38
Earnings History > 11 > eps Difference
-0.02
Earnings History > 11 > surprise Percent
-5.2632
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.33
Earnings History > 12 > eps Estimate
-0.4
Earnings History > 12 > eps Difference
0.07
Earnings History > 12 > surprise Percent
17.5
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-15
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.36
Earnings History > 13 > eps Estimate
-0.3
Earnings History > 13 > eps Difference
-0.06
Earnings History > 13 > surprise Percent
-20
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.22
Earnings History > 14 > eps Estimate
-0.25
Earnings History > 14 > eps Difference
0.03
Earnings History > 14 > surprise Percent
12
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.23
Earnings History > 15 > eps Estimate
-0.25
Earnings History > 15 > eps Difference
0.02
Earnings History > 15 > surprise Percent
8
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.2
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-23
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.51
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0.51
Earnings History > 17 > surprise Percent
-
TransCode Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer. The company's lead therapeutic candidate comprises TTX-MC138 that targets microRNA-10b, a master regulator of metastatic cell viability in various cancers comprising breast, pancreatic, ovarian, colon cancer, glioblastomas, and others. Its preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1 and two indication agnostic programs; TTX-RIGA, an RNA- based agonist of the retinoic acid-inducible gene I targeting activation of innate immunity in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9-based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines that activate cytotoxic immune responses against tumor cells. TransCode Therapeutics, Inc. has strategic collaboration agreement with The University of Texas M. D. Anderson Cancer Center. The company was incorporated in 2016 and is based in Boston, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATransCode Therapeutics To Acquire Polynoma, Receive $25M Investment To Advance Key Asset - MSN
11/22/2025
TransCode Therapeutics To Acquire Polynoma, Receive $25M Investment To Advance Key Asset MSN
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$10
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 11.31% of the total shares of Transcode Therapeutics Inc
1.
Anson Funds Management LP(6.2635%)
since
2025/03/31
2.
Goldman Sachs Group Inc(3.3636%)
since
2025/06/30
3.
Vanguard Institutional Extnd Mkt Idx Tr(0.7851%)
since
2025/07/31
4.
Fidelity Series Total Market Index(0.2167%)
since
2025/07/31
5.
Fidelity Extended Market Index(0.1799%)
since
2025/07/31
6.
UBS Group AG(0.1718%)
since
2025/06/30
7.
Spartan Extended Market Index Pool F(0.1408%)
since
2025/07/31
8.
Spartan Total Market Index Pool G(0.0599%)
since
2025/07/31
9.
SouthState Bank Corp(0.0578%)
since
2025/06/30
10.
Tower Research Capital LLC(0.0482%)
since
2025/06/30
11.
NT Ext Equity Mkt Idx Fd - L(0.0071%)
since
2025/06/30
12.
Northern Trust Extended Eq Market Idx(0.0071%)
since
2025/06/30
13.
Fidelity Total Market Index(0.005%)
since
2025/07/31
14.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.002%)
since
2025/06/30
15.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0017%)
since
2024/12/31
16.
SBI Securities Co Ltd(0.0012%)
since
2025/06/30
17.
Royal Bank of Canada(0.001%)
since
2025/06/30
18.
Bank of America Corp(0.001%)
since
2025/06/30
19.
FMR Inc(0.0004%)
since
2025/06/30
20.
Advisor Group Holdings, Inc.(0.0004%)
since
2025/06/30
21.
Ground Swell Capital, LLC(0%)
since
2025/06/30
22.
Sabby Management LLC(0%)
since
2025/06/30
23.
Warberg Asset Management LLC(0%)
since
2025/06/30
24.
Corsair Capital Management LLC(0%)
since
2025/06/30
25.
Morgan Stanley - Brokerage Accounts(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-5.8248
EPS Estimate
—
EPS Difference
0
Surprise Percent
null%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.